https://pi3kinhibitor.com/inde....x.php/field-work-wel
A starting Ki67 index of 10% is associated with adverse outcomes and manifests as a promising early marker for future metastatic disease. Intensified surveillance and more timely management will be essential consequences of its presence. Local treatments are a critical component of care for clinicians, independent of any systemic therapies that are concurrently employed. An initial Ki67 index, measured at 10%, is associated with an adverse prognosis and ap
お気に入り
コメント
シェア
